Cathrine Ørskov

Cathrine Ørskov

Head of Department

ORCID: 0000-0002-7762-2372

Publication year:
All
21 - 30 out of 116Page size: 10
  1. 1992
  2. Published

    Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects

    Nauck, M. A., Bartels, Emil Daniel, Ørskov, Cathrine, Ebert, R. & Creutzfeldt, W., 1992, In: Digestion. 52, 3-4, p. 214-21 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Basal and nutrient stimulated pancreatic and gastrointestinal hormone concentrations in type-1 diabetes patients after succesful combined pancreas and kidney transplantation

    Nauck, M., Büsing, M., Ørskov, Cathrine, Siegel, E. G., Talartschik, J., Baartz, A., Baartz, T., Hopt, U. T., Ebert, R., Becker, H. & Creutzfeldt, W., 1992, In: Clinical Investigator. 70, p. 40-48

    Research output: Contribution to journal › Journal article › Research

  4. Published

    Glucagon-like peptide-1, a new hormone of the entero-insular axis

    Ørskov, Cathrine, Aug 1992, In: Diabetologia. 35, 8, p. 701-11 11 p.

    Research output: Contribution to journal › Review › Research › peer-review

  5. Published

    All products of proglucagon are elevated in plasma from ureamic patients

    Ørskov, Cathrine, Andreasen, J. & Holst, Jens Juul, 1992, In: Journal of Clinical Endocrinology and Metabolism. 79, p. 379-383

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Glucagon-like peptide-1, a new hormone of the enteroinsular axis

    Ørskov, Cathrine, 1992, In: Diabetologia. 35, p. 701-711

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. 1993
  8. Published

    Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired and diabetic glucose tolerance

    Laang, S., Thorsteinsson, B., Røder, M. E., Ørskov, Cathrine, Holst, Jens Juul, Nerup, J. & Koch, C., 1993, In: Acta Endoctrinologica. 128, p. 207-214

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations

    Nauck, M. A., Bartels, Emil Daniel, Ørskov, Cathrine, Ebert, R. & Creutzfeldt, W., Apr 1993, In: Endocrinology. 76, 4, p. 912-7 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Pres. incretin effect of imm. gastric inhibotory polyp. (GIP) and glucagon-like pept. (GLP-1) after oral glucose in type 1 diab. pat. with end-stage nepr. treated by comb. heter. pancreas a. kidn.tra.

    Nauck, M., Büsing, M., Ørskov, Cathrine, Siegel, E. B., Talartschik, J., Baartz, A., Baartz, T., Hopt, U. T., Ebert, R., Becker, H. & Creutzfeldt, W., 1993, In: Acta Diabetologica. 30, p. 36-45

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable

    Ørskov, Cathrine, Wettergren, A. & Holst, Jens Juul, May 1993, In: Diabetes. 42, 5, p. 658-61 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Biological effects and metabolic rates of GLP-1 7-36 amide and GLP-1 7-37 in healthy volunteers are indistinguishable

    Ørskov, Cathrine, Wettergren, A. & Holst, Jens Juul, 1993, In: Diabetes. 42, p. 658-661

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...12 Next

ID: 137086045